Industrial Purity Standards For 2-Fluoro-5-Hydroxypyridine
- Critical Purity Thresholds: Pharmaceutical-grade material requires ≥98% purity with strict control over isomeric impurities.
- Analytical Validation: GC and HPLC methods are essential for verifying the 148-150°C melting point and chemical identity.
- Supply Chain Security: Partnering with a reliable global manufacturer ensures consistent bulk price stability and COA compliance.
In the landscape of modern pharmaceutical intermediates, the quality of fluorinated pyridine derivatives dictates the success of downstream coupling reactions. 2-Fluoro-5-hydroxypyridine (CAS: 55758-32-2) serves as a critical building block for kinase inhibitors and agrochemical agents. However, variability in industrial purity can lead to catastrophic failures in synthesis scaling. This technical overview delineates the strict quality parameters, analytical validation methods, and manufacturing protocols required for high-grade procurement.
Pharma-Grade Purity Requirements (≥98%) and Analytical Validation
The market standard for pharmaceutical intermediates has shifted decisively toward ≥98% purity, with leading contracts often demanding ≥99%. For 6-fluoropyridin-3-ol, the physical properties serve as the first line of quality control. High-quality material presents as a white to almost white fine crystalline powder with a sharp melting point range of 148-150°C. Deviations from this thermal profile often indicate the presence of residual solvents, unreacted starting materials, or hydrolysis byproducts.
Procurement teams must prioritize suppliers who provide comprehensive data on impurity profiles. Common contaminants include residual halides from the fluorination step or phenolic isomers. At NINGBO INNO PHARMCHEM CO.,LTD., quality assurance protocols enforce rigorous testing beyond simple assay percentages. This ensures that the manufacturing process yields material compatible with sensitive catalytic cycles, minimizing the risk of catalyst poisoning during subsequent nucleophilic aromatic substitution reactions.
Physical and Chemical Specifications
| Parameter | Specification | Test Method |
|---|---|---|
| Chemical Name | 2-Fluoro-5-hydroxypyridine | - |
| CAS Number | 55758-32-2 | - |
| Molecular Formula | C5H4FNO | - |
| Molecular Weight | 113.09 g/mol | - |
| Purity (GC) | ≥ 98.0% - 99.0% | Gas Chromatography |
| Melting Point | 148-150°C | DSC / Capillary |
| Appearance | White to Almost White Powder | Visual |
| Solubility | Soluble in Methanol | Experimental |
GC vs. HPLC Methods for Purity Assessment
Selecting the appropriate analytical technique is vital for accurate quantification. While High-Performance Liquid Chromatography (HPLC) is standard for non-volatile compounds, Gas Chromatography (GC) is often preferred for volatile fluorinated pyridines like this substrate. GC analysis provides superior resolution for detecting low-level volatile impurities that might persist after solvent removal.
However, thermal stability must be considered. Given the boiling point of approximately 319.8±22.0 °C, injector port temperatures must be optimized to prevent degradation during analysis. A robust COA (Certificate of Analysis) will specify the column type, temperature gradient, and internal standards used. Buyers should verify that the reported purity matches the detection method, as GC area normalization can sometimes overestimate purity compared to HPLC with UV detection. Consistency in testing methodology between the supplier and the buyer is essential to avoid disputes upon receipt of bulk shipments.
Optimization of the Synthesis Route
Understanding the underlying chemistry helps procurement officers assess the risk profile of a supply chain. A common synthesis route involves the hydrolysis of 5-Acetoxy-2-fluoropyridine. In this process, the acetoxy precursor is dissolved in aqueous sodium hydroxide (20% NaOH) and stirred at room temperature. Following hydrolysis, the reaction mixture is neutralized with concentrated hydrochloric acid.
The subsequent workup involves extraction with ethyl acetate, drying over anhydrous magnesium sulfate, and concentration under reduced pressure. Final purification via silica gel column chromatography using a chloroform/methanol eluent system typically affords yields around 79%. Industrial scaling of this route requires precise control over the neutralization step to prevent the formation of salts that are difficult to remove. Efficient removal of inorganic salts is critical for achieving the high industrial purity required for GMP applications.
Certificate of Analysis (COA) Essentials for cGMP Compliance
For pharmaceutical clients, the COA is not merely a document but a legal guarantee of quality. A compliant COA must include batch numbers, manufacturing dates, and expiration timelines. It should explicitly list safety statements, such as hazard codes Xi and Xn, and precautionary statements regarding skin and eye irritation (H315, H319). Furthermore, storage conditions must be clearly defined; this material should be kept in a dark place, sealed in dry conditions at room temperature to prevent oxidation or hydrolysis.
When sourcing high-purity 2-Fluoro-5-hydroxypyridine, buyers should ensure the COA reflects real-time batch data rather than generic specifications. Transparency in the supply chain allows for better risk management regarding regulatory filings.
Commercial Viability and Bulk Procurement
Pricing structures for fluorinated intermediates vary significantly based on volume and purity tiers. Lab-scale pricing often exceeds $75 per gram, whereas industrial bulk price agreements can reduce costs to a fraction of that amount per kilogram. However, low cost should never compromise quality. A reliable global manufacturer offers stability in supply capacity, often guaranteeing tonnage availability rather than just kilogram quantities.
Strategic partnerships with established entities like NINGBO INNO PHARMCHEM CO.,LTD. provide access to consistent quality and technical support. This ensures that the intermediate meets the rigorous demands of modern drug discovery pipelines. By focusing on verified synthesis routes, validated analytical methods, and transparent documentation, pharmaceutical companies can secure a supply chain that supports innovation without compromising on safety or efficacy.